The Scientist

» biotechnology and microbiology

Most Recent

image: Broad Wins CRISPR Patent Interference Case

Broad Wins CRISPR Patent Interference Case

By | February 15, 2017

The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

6 Comments

image: Toward Killing Cancer with Bacteria

Toward Killing Cancer with Bacteria

By | February 8, 2017

Researchers employ an engineered microbe to destroy tumor cells in mice.

0 Comments

image: Discovering Novel Antibiotics

Discovering Novel Antibiotics

By | February 1, 2017

Three methods identify and activate silent bacterial gene clusters to uncover new drugs

0 Comments

image: Opinion: Preparing for Potential Disasters

Opinion: Preparing for Potential Disasters

By | January 25, 2017

How to increase the resiliency of biotechnology organizations in the face of emergency risks

0 Comments

Study of 81 six-week-olds who were born by C-section or vaginal delivery didn’t show differences in the structure or function of their microbiota, despite contrary results from other studies on babies. 

4 Comments

image: How Plant-Soil Feedback Affects Ecological Diversity

How Plant-Soil Feedback Affects Ecological Diversity

By | January 13, 2017

Researchers examine how underground microbes and nutrients affect plant populations.

0 Comments

image: Drug Approval Timeline Same as 20 Years Ago

Drug Approval Timeline Same as 20 Years Ago

By | January 9, 2017

A report finds that new medications still take about 12 years to go from patent to patient.

0 Comments

image: More Anti-CRISPR Proteins to Block Cas9

More Anti-CRISPR Proteins to Block Cas9

By | December 29, 2016

The latest CRISPR deactivators to be discovered turn off the Streptococcus pyogenes Cas9 widely used in genome editing.

0 Comments

image: New CRISPR-Cas Enzymes Discovered

New CRISPR-Cas Enzymes Discovered

By | December 22, 2016

A metagenomics analysis finds Cas9 in archaea for the first time, along with two previously unknown Cas nucleases from bacteria.

1 Comment

On Tuesday, shareholders at the agribusiness giant approved the $66 billion deal with the European pharmaceutical firm.

0 Comments

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Researchers Build a Cancer Immunotherapy Without Immune Cells
  3. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

  4. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
RayBiotech